Steen Jeremy P, Kannan Vivek, Zaidi Abdullah, Cramer Holger, Ng Jeremy Y
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
Institute of General Practice and Interprofessional Care, University Hospital Tübingen, Tübingen, Germany.
Pain Med. 2024 Aug 2;25(12):703-37. doi: 10.1093/pm/pnae076.
Fibromyalgia is a chronic and disabling condition that presents management challenges for both patients and healthcare providers. The objective of this systematic review was to summarize current evidence on the effectiveness and safety of mind-body therapies in the treatment and/or management of fibromyalgia.
We searched MEDLINE, EMBASE, PsycINFO, AMED, and CINAHL databases from their inception to December 2023. Eligible articles included adults diagnosed with fibromyalgia participating in a mind-body therapy intervention and were published from the beginning of 2012 onwards. We assessed the quality of the studies using the Joanna Briggs Institute Critical Appraisal Checklists.
Of 3866 records screened, 27 studies (30 articles) met our inclusion criteria, in which 22 were randomized controlled trials and 5 were quasi-experimental studies. Mind-body therapies included guided imagery (n = 5), mindfulness-based stress reduction (n = 5), qi gong (n = 5), tai chi (n = 5), biofeedback (n = 3), yoga (n = 2), mindfulness awareness training (n = 1), and progressive muscle relaxation (n = 1). With the exception of mindfulness-based stress reduction, all therapies had at least one study showing significant improvements in pain at the end of treatment. Multiple studies on guided imagery, qi gong, and tai chi observed significant improvements in pain, fatigue, multidimensional function, and sleep. Approximately one-third of the studies reported on adverse events.
This review suggests that mind-body therapies are potentially beneficial for adults with fibromyalgia. Further research is necessary to determine if the positive effects observed post-intervention are sustained.
Open Science Framework (https://osf.io) (September 12, 2023; https://doi.org/10.17605/osf.io/6w7ac).
纤维肌痛是一种慢性致残性疾病,给患者和医疗服务提供者带来了管理挑战。本系统评价的目的是总结身心疗法在纤维肌痛治疗和/或管理中的有效性和安全性的现有证据。
我们检索了MEDLINE、EMBASE、PsycINFO、AMED和CINAHL数据库,检索时间从各数据库建库至2023年12月。符合条件的文章包括2012年初以来发表的、诊断为纤维肌痛的成年人参与身心疗法干预的研究。我们使用乔安娜·布里格斯研究所批判性评价清单评估研究质量。
在筛选的3866条记录中,27项研究(30篇文章)符合我们的纳入标准,其中22项为随机对照试验,5项为准实验研究。身心疗法包括引导式意象法(n = 5)、基于正念的减压法(n = 5)、气功(n = 5)、太极拳(n = 5)、生物反馈法(n = 3)、瑜伽(n = 2)、正念觉知训练(n = 1)和渐进性肌肉松弛法(n = 1)。除基于正念的减压法外,所有疗法至少有一项研究表明治疗结束时疼痛有显著改善。多项关于引导式意象法、气功和太极拳的研究观察到疼痛、疲劳、多维度功能和睡眠有显著改善。约三分之一的研究报告了不良事件。
本综述表明身心疗法对患有纤维肌痛的成年人可能有益。有必要进一步研究以确定干预后观察到的积极效果是否能持续。
开放科学框架(https://osf.io)(2023年9月12日;https://doi.org/10.17605/osf.io/6w7ac)。